Company Eurovetpharm Srl with Fiscal Code 8089314
recorded a turnover of 2024 of
22.411,
with a net profit of
31.459
and having an average number of employees of
1.
The company operates in the field of Activităţi veterinare having the NACE code 7500.
Sales - Ron
Sales, Profit, Employees, Total Income, Financial Results -
Eurovetpharm Srl
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Sales - EUR
18.360
22.669
25.097
29.511
24.543
27.849
55.478
46.745
46.022
22.411
Total Income - EUR
18.360
22.671
25.103
29.512
24.544
27.858
55.489
46.757
46.440
64.709
Total Expenses - EUR
14.136
15.900
21.350
28.783
22.930
24.205
43.929
30.088
18.721
32.702
Gross Profit/Loss - EUR
4.224
6.770
3.753
729
1.615
3.653
11.560
16.669
27.719
32.007
Net Profit/Loss - EUR
3.673
6.544
3.248
434
1.366
3.393
11.100
16.106
27.255
31.459
Employees
0
2
3
2
2
2
2
1
1
1
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded.
In the last year of activity, the sales decreased by -51.0%, from 46.022 euro in the year 2023, to 22.411 euro in 2024.
The Net Profit increased by 4.356 euro, from 27.255 euro in 2023, to 31.459 in the last year.
Check the financial reports for the company - Eurovetpharm Srl
Financial Rating - EUROVETPHARM SRL
See the company's note based on the submitted financial data, relative to the industry of which it is a part.
Financial Rating
Payment Limits - Eurovetpharm Srl
See the company's payment capacity for situations in which you conclude contracts with payment terms.
Check Payment Limits
Prob. of insolvency - Eurovetpharm Srl
It determines the risk of insolvency based on the submitted accounting balance.
Insolvency Probability
Financial Reports - Eurovetpharm Srl
Check all the financial reports of the company and know the risks in collaboration with it.
Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of
47.413 euro in 2024 which includes Inventories of
268 euro, Receivables of
3.233 euro and cash availability of
43.912 euro.
The company's Equity was valued at
53.531 euro, while total Liabilities amounted to
1.521 euro.
Equity increased by 9.877 euro, from 43.899 euro in 2023, to 53.531 in 2024.
Similar services useful for checking companies and business development.
SellNet
Get the contact details for any company and get in touch with it.
Sectoral Studies
Knows the market and develops its own development strategies according to sectorial data.
Databases
Export in excel files the data of the companies selected according to the desired criteria.
Import - Export
Find importers and exporters according to the type of activity and the countries in which they carry it out.
Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.
Comments - Eurovetpharm Srl